Current position in this corpus
Several papers in this corpus are best understood as second-wave protocols: they assume an organoid already exists, then teach how to expose it to microbes, immune cells, injury models, or host tissue.
Strong supporting sources
Working synthesis
- These workflows matter because many organoid questions are really assay-design problems rather than derivation problems.
- They often determine whether the resulting model is useful for infection, immune interaction, repair, or circuit-engagement questions.
- Their success depends heavily on the maturity, polarity, and baseline quality of the starting organoid culture.
Main tension
- baseline organoid robustness versus sophistication of the downstream assay layer
- controlled in vitro exposure versus more realistic but noisier in vivo validation
Open questions
- What baseline maturity or polarity is required before a coculture or transplantation result is believable?
- Which assays genuinely add biological insight rather than just technical complexity?